ORY-1001, a potent and selective covalent KDM1A inhibitor, for the treatment of Acute Leukemia (Sample4)
Published: 5 March 2018| Version 1 | DOI: 10.17632/r86k8mwpn6.1
Contributor:
tamara maesDescription
Sample4 THP-1 H3K4me2 ChIPSeq data after ORY-1001 treatment
Files
Institutions
Oryzon
Categories
Epigenetics